The Importance of Stereochemistry in Drug Action and Disposition
- 1 October 1992
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 32 (10) , 925-929
- https://doi.org/10.1002/j.1552-4604.1992.tb04640.x
Abstract
Many biologically active synthetic drugs contain chiral centers, although they are used as racemic mixtures. Enantiomers are hard to distinguish in the chemical laboratory but are readily discriminated in the body and differ in their biological activities and disposition. The pharmacokinetic profiles of enantiomers can be variable, especially for drugs with a first-pass effect and enantioselective pharmacokinetic monitoring should be carried out. Ultimately, whether to exploit a racemate or a single enantiomer in therapy is a multi-faceted decision to which drug disposition data have important contributions to make.Keywords
This publication has 19 references indexed in Scilit:
- Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug developmentChirality, 1991
- Regulatory aspects of the development of chiral drugs in Japan: A status reportChirality, 1991
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1984
- The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequencesJournal of Pharmacy and Pharmacology, 1983
- The Metabolism of Amphetamines in MammalsDrug Metabolism Reviews, 1976
- The Influence of Stereochemical Factors on Drug DispositionDrug Metabolism Reviews, 1974
- Pharmacokinetics of (+)-, (−)- and (±)-hexobarbitone in man after oral administrationJournal of Pharmacy and Pharmacology, 1973
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970